Primary Record
Bluensomycin
- In stock
- 8,673 g
- Purity
- 99.5 %
- CAS
- 11011-72-6
Compound Identifiers & Properties
- CAS
- 11011-72-6
- PubChem CID
- 20055290
- SMILES
- C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)OC(=O)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(CO)O
- Canonical SMILES
- CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](OC(N)=O)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O
Names & Synonyms
- Bluensomycin
- Bluensomicina
- Bluensin
- Bluensomycine
- Bluensomycinum
- Glebomycin
- Bluensomycin [INN]
- LWV7PWE57U
- UNII-LWV7PWE57U
- Bluensomycine [INN-French]
- Bluensomycinum [INN-Latin]
- RefChem:120663
- Bluensomicina [INN-Spanish]
- SCHEMBL691672
- U-12898
- CHEMBL2104642
- CHEBI:81193
- GTPL10765
- DTXSID10891345
- DTXCID501030500
- 11011-72-6
- C21H39N5O14
- ZINC8214505
- BBF-00580
- U 12898D
- C21-H39-N5-O14
- J78.084G
- U-12898D
- NS00011554
- U 12898
- Ascomycin /Immunomycin/FR-900520/FK-520
- C17573
- U12898
- [(1R,2S,3S,4R,5R,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl] carbamate
- Q27155138
- ((1R,2S,3S,4R,5R,6R)-3-(diaminomethylideneamino)-4-((2R,3R,4R,5S)-3-((2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl)oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl)oxy-2,5,6-trihydroxycyclohexyl) carbamate
- ((1S,2S,3S,4S,5R,6R)-3-(diaminomethylideneamino)-4-((2R,3R,4R,5S)-3-((2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl)oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl)oxy-2,5,6-trihydroxycyclohexyl) carbamate
- (1R,2S,3S,4R,5R,6R)-3-Carbamimidamido-4-({5-deoxy-2-O-[2-deoxy-2- (methylamino)-|A-L-glucopyranosyl]-3-C-(hydroxymethyl)-|A-L-lyxofur anosyl}oxy)-2,5,6-trihydroxycyclohexyl carbamate
- (1R,2S,3S,4R,5R,6R)-3-CARBAMIMIDAMIDO-4-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-3-(METHYLAMINO)OXAN-2-YL]OXY}-4-HYDROXY-4-(HYDROXYMETHYL)-5-METHYLOXOLAN-2-YL]OXY}-2,5,6-TRIHYDROXYCYCLOHEXYL CARBAMATE
- 2-O-(5-Deoxy-3-C-(hydroxymethyl)-2-O-(2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl)-alpha-L-lyxofuranosyl)-1-(amidinoamino)-1-deoxy-5-O-carbamoyl-D-scyllo-inositol
- 2-O-[2-O-[2-(Methylamino)-2-deoxy-alpha-L-glucopyranosyl]-3-C-hydroxymethyl-5-deoxy-alpha-L-lyxofuranosyl]-1-(aminoiminomethylamino)-5-O-carbamoyl-1-deoxy-D-scyllo-inositol
- 2-O-[5-Deoxy-3-C-(hydroxymethyl)-2-O-[2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl]-alpha-L-lyxofuranosyl]-1-(amidinoamino)-1-deoxy-5-O-carbamoyl-D-scyllo-inositol
- Antibiotic obtained from cultures of Streptomyces verticillus, or the same substance produced by any other means
- D-scyllo-Inositol, O-2-deoxy-2-(methylamino)-.alpha.-L-glucopyranosyl-(1.fwdarw.2)-O-5-deoxy-3-C-(hydroxymethyl)-.alpha.-L-lyxofuranosyl-(1.fwdarw.2)-1-[(aminoiminomethyl)amino]-1-deoxy-, 5-carbamate
- D-scyllo-Inositol, O-2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1=>2)-O-5-deoxy-3-C-(hydroxymethyl)-alpha-L-lyxofuranosyl-(1=>2)-1-((aminoiminomethyl)amino)-1-deoxy-, 5-carbamate